Learning objectives: Recognize important type 2 diabetes trials published in the last 3 years regarding SGLT2 inhibitors, GLP-1 receptor agonists and insulin.

Incorporate these findings into a clinical pathways in type 2 diabetes management.

Session date: 
05/08/2018 - 12:00pm to 1:00pm CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
John B. Buse, MD, PhD